Large international study will help select and categorize patients for better clinical trials
A large multi-centre study of more than 1,200 patients provides important predictors of Parkinson’s disease progression, which will allow better candidate selection for clinical trials and more effective therapy development.
Scientists prove difference between expected/actual outcomes cause reward response
If you love it when a musician strikes that unexpected but perfect chord, you are not alone. New research shows the musically unexpected activates the reward centre of our brains, and makes us learn about the music as we listen.
Scanner will deliver clear images of the nervous system in exceptional detail
Scientists will see the human nervous system in microscopic detail thanks to the installation of Canada’s first 7-Tesla whole-body magnetic resonance imaging (MRI) scanner on Feb. 5.
A new study published in the prestigious Proceedings of the National Academy of Science, reveals a causal link between the neurotransmitter dopamine and the reward responses to music. The study was conducted by an international team including researchers from the Montreal Neurological Institute and Hospital of McGill University, the University of Barcelona, and the Hospital de Sant Pau of Barcelona.
Reducing stigma may address cognitive impairment in this population
A new study has drawn a direct link between the amount of stigma men with HIV report experiencing and their scores on cognitive tests, measuring abilities such as memory and attention.
A researcher from the Montreal Neurological Institute and Hospital (The Neuro) is one of eight scientists to receive a grant this year from the ALS Society of Canada.
Providing excellent care and the latest research to help patients
The Brain Tumour Foundation of Canada estimates that 27 Canadians a day are diagnosed with a brain tumour and 55,000 are living with one. This Brain Tumour Awareness Week we recognize the toll this disease takes on patients and the work being done to improve their quality of life.
Brain cancer begins in stem cells, targeting them may prevent tumour growth
Researchers at the Montreal Neurological Institute and Hospital (The Neuro) have found an exciting new way of treating brain cancer.
Late stage brain cancer cells are heterogeneous — they differ down to the molecular level. This makes developing treatments at this stage difficult, because a drug that may be effective against one cell may not be effective against another.
Carriers at higher risk of developing neurodegenerative disease
A team of Canadian scientists, including researchers at the Montreal Neurological Institute and Hospital (The Neuro) has discovered the first French-Canadian founder mutation gene linked to synucleinopathies, a group of neurodegenerative diseases that includes Parkinson’s disease (PD), dementia with Lewy-Bodies (DLB) and multiple system atrophy (MSA).
When it comes to weight gain, the problem may be mostly in our heads, and our genes
Clinicians should consider how the way we think can make us vulnerable to obesity, and how obesity is genetically intertwined with brain structure and mental performance, according to new research.
Scientist Brenda Milner, born in 1918, pioneered memory research
Pioneering neuropsychologist Brenda Milner turns 100 today. Milner made groundbreaking discoveries in the field of human memory.
Technique can be used to better categorize patients with neurological disease, according to their therapeutic needs
Personalized medicine – delivering therapies specially tailored to a patient’s unique physiology – has been a goal of researchers and doctors for a long time. New research provides a way of delivering personalized treatments to patients with neurological disease.